Cart
sales@molnova.com
alpha-(3,4-Dihydroxyphenyl)lactic acid
CAS No. 22681-72-7
alpha-(3,4-Dihydroxyphenyl)lactic acid( —— )
Catalog No. M18269 CAS No. 22681-72-7
Danshensu has antioxidant activity, can enhance HO-1 expression to suppress 6-OHDA-induced oxidative damage via PI3K/Akt/Nrf2 signaling pathways.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namealpha-(3,4-Dihydroxyphenyl)lactic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDanshensu has antioxidant activity, can enhance HO-1 expression to suppress 6-OHDA-induced oxidative damage via PI3K/Akt/Nrf2 signaling pathways.
-
DescriptionDanshensu has antioxidant activity, can enhance HO-1 expression to suppress 6-OHDA-induced oxidative damage via PI3K/Akt/Nrf2 signaling pathways.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22681-72-7
-
Formula Weight198.17
-
Molecular FormulaC9H10O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(c1cc(c(cc1)O)O)(C(=O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kwon G1, Kim HJ2, Park SJ1,et al.Anxiolytic-like effect of danshensu [(3-(3,4-dihydroxyphenyl)-lactic acid)] in mice.Life Sci. 2014 Apr 17;101(1-2):73-8.
molnova catalog
related products
-
trans-12-Cyclohexane...
14-cyclohexanediol and 12-hexanediol have a synergistic retardation effect on percutaneous absorption and penetration of metronidazole (MTZ).
-
Dasatinib carbaldehy...
Dasatinib carbaldehyde (PROTAC ABL binding moiety 4) is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER .
-
c(Bua-Cpa-Thi-Val-As...
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm a highly efficient, selective and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.
